| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.15B | 40.53B | 39.27B | 39.15B | 34.37B | 29.32B |
| Gross Profit | 20.47B | 20.41B | 19.56B | 18.27B | 15.87B | 13.64B |
| EBITDA | 9.43B | 9.04B | 9.67B | 9.67B | 8.44B | 7.13B |
| Net Income | 5.86B | 5.46B | 6.19B | 6.33B | 5.33B | 4.52B |
Balance Sheet | ||||||
| Total Assets | 45.82B | 51.49B | 48.16B | 45.25B | 40.61B | 36.39B |
| Cash, Cash Equivalents and Short-Term Investments | 16.46B | 18.53B | 18.32B | 16.53B | 13.62B | 16.02B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 5.14B | 7.54B | 8.34B | 8.13B | 7.83B | 6.94B |
| Stockholders Equity | 40.68B | 43.96B | 39.82B | 37.12B | 32.78B | 29.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.29B | 5.35B | 5.43B | -50.90M | 4.05B |
| Operating Cash Flow | 0.00 | 7.52B | 8.87B | 8.44B | 1.24B | 4.70B |
| Investing Cash Flow | 0.00 | -4.73B | -3.75B | -3.35B | -1.48B | -826.26M |
| Financing Cash Flow | 0.00 | -2.71B | -3.60B | -2.32B | -2.46B | -1.43B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥84.06B | 15.28 | ― | 3.23% | 7.28% | 4.16% | |
76 Outperform | ¥224.89B | 13.88 | ― | 1.88% | 6.56% | 106.55% | |
75 Outperform | ¥76.84B | 13.73 | ― | 3.12% | 2.78% | -5.32% | |
74 Outperform | ¥309.08B | 26.61 | ― | 1.49% | 18.20% | 28.13% | |
71 Outperform | ¥86.52B | 12.48 | ― | 1.68% | 2.72% | 33.10% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |